Literature DB >> 23574755

Association between cystatin C and arteriosclerosis in the absence of chronic kidney disease.

Hiroshi Yamashita1, Tomoya Nishino, Yoko Obata, Mio Nakazato, Keita Inoue, Akira Furusu, Noboru Takamura, Takahiro Maeda, Yoshiyuki Ozono, Shigeru Kohno.   

Abstract

AIM: Chronic kidney disease (CKD) is a known risk factor for cardiovascular disease (CVD). Cystatin C was recently reported to be an endogenous surrogate of kidney function, and a high level of cystatin C is reported to be a strong predictor of CVD; however, the association between cystatin C and arteriosclerosis in a non-CKD population is unclear. This study aimed to clarify the association between cystatin C and arteriosclerosis in a non-CKD population.
METHODS: Of the 637 Japanese adults (264 men, 373 women) enrolled, we analyzed 446 participants with an estimated glomerular filtration rate (eGFR) >60 mL/min and no proteinuria (177 men, 269 women) without a history of CVD. Kidney function was evaluated according to serum cystatin C levels and eGFR. Arteriosclerosis was evaluated on the basis of the cardio-ankle vascular index (CAVI) and carotid intima-media thickness (CIMT).
RESULTS: The mean age of our subjects was 67.0±10.0 years. No variables showed any significant differences according to gender. The results of multiple linear regression analysis showed a significant correlation between serum cystatin C and CAVI only in women, but not CIMT.
CONCLUSION: We observed a significant correlation between cystatin C and CAVI, which is a marker of early-stage arteriosclerosis, in women in a non-CKD population with no proteinuria and eGFR>60 mL/min.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23574755     DOI: 10.5551/jat.13193

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  7 in total

1.  Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus.

Authors:  Patricia Garcia-Garcia; Raquel Castejon; Pablo Tutor-Ureta; R A Silvestre; Susana Mellor-Pita; Carlos Jimenez-Ortiz; Miguel Yebra-Bango
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

2.  Association between high cystatin C levels and carotid atherosclerosis.

Authors:  Toshiyuki Kobayashi; Hirohide Yokokawa; Kazutoshi Fujibayashi; Tomomi Haniu; Teruhiko Hisaoka; Hiroshi Fukuda; Toshio Naito
Journal:  World J Cardiol       Date:  2017-02-26

3.  Serum cystatin C is an independent biomarker associated with the renal resistive index in patients with chronic kidney disease.

Authors:  Ayu Ogawa-Akiyama; Hitoshi Sugiyama; Masashi Kitagawa; Keiko Tanaka; Akifumi Onishi; Toshio Yamanari; Hiroshi Morinaga; Haruhito Adam Uchida; Kazufumi Nakamura; Hiroshi Ito; Jun Wada
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

Review 4.  New Horizons of Arterial Stiffness Developed Using Cardio-Ankle Vascular Index (CAVI).

Authors:  Atsuhito Saiki; Masahiro Ohira; Takashi Yamaguchi; Daiji Nagayama; Naomi Shimizu; Kohji Shirai; Ichiro Tatsuno
Journal:  J Atheroscler Thromb       Date:  2020-06-26       Impact factor: 4.928

5.  Serum cystatin C is associated with the prognosis in acute myocardial infarction patients after coronary revascularization: a systematic review and meta-analysis.

Authors:  Jun Chen; Yang Yang; Chuxing Dai; Yimin Wang; Rui Zeng; Qiang Liu
Journal:  BMC Cardiovasc Disord       Date:  2022-04-07       Impact factor: 2.298

6.  Serum Cystatin C and Arterial Stiffness in Middle-Aged and Elderly Adults without Chronic Kidney Disease: A Population-Based Study.

Authors:  Xiaolin Huang; Xiaohong Jiang; Long Wang; Zhenyu Liu; Yang Wu; Pei Gao; Xuegan Lian; Fei Hua
Journal:  Med Sci Monit       Date:  2019-12-03

7.  Independent associations of urinary albumin-to-creatinine ratio and serum cystatin C with carotid intima-media thickness in community-living Taiwanese adults.

Authors:  Chiu-Shong Liu; Chia-Ing Li; Yuh-Cherng Guo; Chih-Hsueh Lin; Wen-Yuan Lin; Chung-Hsiang Liu; Mu-Cyun Wang; Chuan-Wei Yang; Shing-Yu Yang; Tsai-Chung Li; Cheng-Chieh Lin
Journal:  BMC Nephrol       Date:  2020-10-31       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.